等待开盘 04-01 09:30:00 美东时间
+0.130
+0.81%
Burning Rock Biotech (NASDAQ:BNR) reported quarterly losses of $(0.20) per share. This is a 81.82 percent increase over losses of $(1.10) per share from the same period last year. The company reported $18.063 million in
03-12 19:27
2026年1月22日-23日,由乐赢投资、国投证券国际、投研会联合主办,智信财经、东莞市私募基金业协会、建国路128号联袂承办,以“聚能创新 共话湾区”为主题举...
01-26 16:22
Burning Rock Biotech Breast Cancer NGS CDx Kit Enters CMDE Priority Review Channel Burning Rock Biotech Ltd. announced that its self-developed "OncoScreen® BCMatch Tissue Kit," a breast cancer NGS companion diagnostic (CDx) kit, has entered the Priority Review Channel of the Center for Medical Devic
01-26 15:13
Gainers IO Biotech (NASDAQ:IOBT) stock increased by 76.7% to $0.37 during Thur...
01-23 01:05
继昨日股价大涨18.49%之后,周四,燃石医学(BNR.US)再度涨逾10%,报31.483美元。
01-15 23:19